Logo
Nazad
S. Čučnik, T. Kveder, A. Artenjak, Z. U. Gallova, J. Swadźba, J. Musial, T. Iwaniec, L. Stojanovich, C. Alessandri, G. Valesini, T. Avčin, J. Tervaert, B. Rozman, B. Božič
24 1. 6. 2012.

Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome

Antibodies against β2-glycoprotein I (anti-β2GPI) are one of the hallmarks of the antiphospholipid syndrome (APS). However, they are heterogenic regarding their epitope specificity, pathogenic mechanisms and their avidity. In the current study we present some outstanding issues about avidity of anti-β2GPI antibodies. Our results confirmed that high avidity anti-β2GPI are associated with thrombosis and APS, while in low avidity anti-β2GPI group non-APS (predominantly systemic lupus erythematosus) patients prevailed.


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više